The point is that even for Apple, engaging on healthcare is risky. Yes, margins are available at volume, but it's not their standard modus operandi given the co

The point is that even for Apple, engaging on healthcare is risky. Yes, margins are available at volume, but it's not their standard modus operandi given the costs of regulation and reimbursement.